The prospective InterAct case-cohort study conducted in 26 centers in eight European countries, is investigating how genetics and lifestyle interact to affect diabetes risk. ... Waist circumference is just as important as other risk factors for diabetes
Little treatments, lots of time best for back pain | Internal Medicine Meeting 2019 News | ACP Internist
catastrophizing, avoiding activities out of fear (of further injury, for example), and having depression, anxiety, obesity, comorbidities such as diabetes, headaches, or asthma, or a physically demanding job, Dr.
31, 2015. Canaglifozin (Invokana) tablets, to improve glycemic control in adults with type 2 diabetes, along with diet and exercise. ... It should not be used in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment or end-stage
found. Researchers conducted a retrospective cohort study of more than 584,000 encounters for more than 27,000 patients with diabetes and elevated A1C, blood pressure and/or LDL. ... Many studies have shown that midlevel providers can be more effective
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a ... Empagliflozin (Jardiance) to treat type 2
Peters said. Metformin is the preferred first-line treatment for type 2 diabetes. ... For type 2 diabetes, the standard deviation 3 should be less than three times the mean.
QD: News Every Day--Teens with type 2 diabetes likely to need combination therapy sooner. ... A majority of teenagers with type 2 diabetes may require combination treatment or insulin therapy within a few years of diagnosis, researchers concluded.
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
QD: News Every Day--'Made in America' fast food associated with heart disease, diabetes. ... The export of American fast food restaurants to Singapore was associated with a spike in diabetes and cardiovascular diseases there, a study found.
In a safety review, the FDA identified 73 cases of ketoacidosis in patients with type 1 or type 2 diabetes treated with SGLT2 inhibitors and 19 cases of life-threatening urosepsis ... The most common adverse reaction was generalized pruritus. A notice